MedPath

Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutatio

Not Applicable
Conditions
hereditary breast and ovarian cancer: HBOC
Registration Number
JPRN-UMIN000023606
Lead Sponsor
Kindai University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

no mutation of BRCA1/2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)safety of RRSO 2)5year overall survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath